The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables

References

• Cepok S, Zhou D, Vogel F, et al. The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis. Arch Neurol. 2003;60(6):849–855.
   PubMedGoogle Scholar
• Rupprecht TA, Koedel U, Fingerle V, et al. The pathogenesis of Lyme neuroborreliosis: from infection to inflammation. Mol Med. 2008;14(3–4):205–212.
   PubMed Web of Science ®Google Scholar
• Cerar T, Ogrinc K, Lotric-Furlan S, et al. Diagnostic value of cytokines and chemokines in Lyme neuroborreliosis. Clin Vaccine Immunol. 2013;20(10):1578–1584.
   PubMedGoogle Scholar
• Henningsson AJ, Tjernberg I, Malmvall BE, et al. Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study. J Neuroinflammation. 2011;8(1):36.
   PubMedGoogle Scholar
• Pietikainen A, Maksimow M, Kauko T, et al. Cerebrospinal fluid cytokines in Lyme neuroborreliosis. J Neuroinflammation. 2016;13(1):273.
   PubMedGoogle Scholar
• Gyllemark P, Forsberg P, Ernerudh J, et al. Intrathecal Th17- and B cell-associated cytokine and chemokine responses in relation to clinical outcome in Lyme neuroborreliosis: a large retrospective study. J Neuroinflammation. 2017;14(1):27.
   PubMedGoogle Scholar
• Rupprecht TA, Plate A, Adam M, et al. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation. 2009;6:42.
   PubMed Web of Science ®Google Scholar
• Xing J, Radkay L, Monaco SE, et al. Cerebrospinal fluid cytology of Lyme neuroborreliosis: a report of 3 cases with literature review. Acta Cytol. 2015;59(4):339–344.
   PubMed Web of Science ®Google Scholar
• Barstad B, Tveitnes D, Noraas S, et al. Cerebrospinal fluid B-lymphocyte chemoattractant CXCL13 in the diagnosis of acute Lyme neuroborreliosis in children. Pediatr Infect Dis J. 2017;36(12):e286–e292.
   PubMed Web of Science ®Google Scholar
• Hytonen J, Kortela E, Waris M, et al. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation. J Neuroinflammation. 2014;11:103.
   PubMed Web of Science ®Google Scholar
• Ljostad U, Mygland A. CSF B-lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J Neurol. 2008;255(5):732–737.
   PubMed Web of Science ®Google Scholar
• Schmidt C, Plate A, Angele B, et al. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology. 2011;76(12):1051–1058.
   PubMed Web of Science ®Google Scholar
• Senel M, Rupprecht TA, Tumani H, et al. The chemokine CXCL13 in acute neuroborreliosis. J Neurol Neurosurg Psychiatry. 2010;81(8):929–933.
   PubMed Web of Science ®Google Scholar
• Sillanpää H, Skogman BH, Sarvas H, et al. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children. Scand J Infect Dis. 2013;45(7):526–530.
   PubMed Web of Science ®Google Scholar
• Tjernberg I, Henningsson AJ, Eliasson I, et al. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis. J Infect. 2011;62(2):149–158.
   PubMed Web of Science ®Google Scholar
• Wutte N, Berghold A, Loffler S, et al. CXCL13 chemokine in pediatric and adult neuroborreliosis. Acta Neurol Scand. 2011;124(5):321–328.
   PubMed Web of Science ®Google Scholar
• Rupprecht TA, Manz KM, Fingerle V, et al. Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis. Clin Microbiol Infect. 2018;24(12):1234.
   PubMed Web of Science ®Google Scholar
• Broekhuijsen-van Henten DM, Braun KP, Wolfs TF. Clinical presentation of childhood neuroborreliosis; neurological examination may be normal. Arch Dis Child. 2010;95(11):910–914.
   PubMed Web of Science ®Google Scholar
• Skogman BH, Croner S, Nordwall M, et al. Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome. Pediatr Infect Dis J. 2008;27(12):1089–1094.
   PubMed Web of Science ®Google Scholar
• Tveitnes D, Øymar K, Natås O. Laboratory data in children with Lyme neuroborreliosis, relation to clinical presentation and duration of symptoms. Scand J Infect Dis. 2009;41(5):355–362.
   PubMed Web of Science ®Google Scholar
• Stanek G, Strle F. Lyme borreliosis. Lancet. 2003;362(9396):1639–1647.
   PubMed Web of Science ®Google Scholar
• Barstad B, Quarsten H, Tveitnes D, et al. Direct molecular detection and genotyping of Borrelia burgdorferi Sensu Lato in cerebrospinal fluid of children with Lyme neuroborreliosis. J Clin Microbiol. 2018;56(5):pii: e01868-17.
   Web of Science ®Google Scholar
• Busch U, Hizo-Teufel C, Boehmer R, et al. Three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. afzelii, and B. garinii) identified from cerebrospinal fluid isolates by pulsed-field gel electrophoresis and PCR. J Clin Microbiol. 1996;34(5):1072–1078.
   PubMed Web of Science ®Google Scholar
• Eiffert H, Ohlenbusch A, Christen HJ, et al. Nondifferentiation between Lyme disease spirochetes from vector ticks and human cerebrospinal fluid. J Infect Dis. 1995;171(2):476–479.
   PubMed Web of Science ®Google Scholar
• Lebech AM. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification. APMIS Suppl. 2002;105:1–40.
   Google Scholar
• Ornstein K, Berglund J, Bergstrom S, et al. Three major Lyme Borrelia genospecies (Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii) identified by PCR in cerebrospinal fluid from patients with neuroborreliosis in Sweden. Scand J Infect Dis. 2002;34(5):341–346.
   PubMed Web of Science ®Google Scholar
• Ruzic-Sabljic E, Lotric-Furlan S, Maraspin V, et al. Analysis of Borrelia burgdorferi sensu lato isolated from cerebrospinal fluid. APMIS. 2001;109(10):707–713.
   PubMed Web of Science ®Google Scholar
• Strle F, Ruzic-Sabljic E, Cimperman J, et al. Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid. Clin Infect Dis. 2006;43(6):704–710.
   PubMed Web of Science ®Google Scholar
• Barrera-Gomez J, Basagana X. Models with transformed variables: interpretation and software. Epidemiology (Cambridge, Mass). 2015;26(2):e16–e17.
   PubMed Web of Science ®Google Scholar
• Henningsson AJ, Lager M, Brannstrom R, et al. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis. Eur J Clin Microbiol Infect Dis. 2018;37(10):1983–1991.
   PubMed Web of Science ®Google Scholar
• Markowicz M, Schotta AM, Kundi M, et al. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA. Ticks Tick Borne Dis. 2018;9(5):1137–1142.
   PubMed Web of Science ®Google Scholar
• van Burgel ND, Bakels F, Kroes AC, et al. Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid. J Clin Microbiol. 2011;49(5):2027–2030.
   PubMed Web of Science ®Google Scholar
• Bremell D, Mattsson N, Edsbagge M, et al. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection. BMC Neurol. 2013;13:2.
   PubMed Web of Science ®Google Scholar
• Rupprecht TA, Lechner C, Tumani H, et al. CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine. Nervenarzt. 2014;85(4):459–464.
   PubMed Web of Science ®Google Scholar
• Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta. 2001;310(2):173–186.
   PubMed Web of Science ®Google Scholar
• Reiber H. Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci. 2003;21(3–4):79–96.
   PubMed Web of Science ®Google Scholar
• Asgari M, de Zelicourt DA, Kurtcuoglu V. Barrier dysfunction or drainage reduction: differentiating causes of CSF protein increase. Fluids Barriers CNS. 2017;14(1):14.
   PubMedGoogle Scholar
• Tveitnes D, Oymar K. Gender differences in childhood Lyme neuroborreliosis. Behav Neurol. 2015;2015:1.
   Google Scholar
• Cabral ES, Gelderblom H, Hornung RL, et al. Borrelia burgdorferi lipoprotein-mediated TLR2 stimulation causes the down-regulation of TLR5 in human monocytes. J Infect Dis. 2006;193(6):849–859.
   PubMed Web of Science ®Google Scholar
• Rupprecht TA, Kirschning CJ, Popp B, et al. Borrelia garinii induces CXCL13 production in human monocytes through Toll-like receptor 2. Infect Immun. 2007;75(9):4351–4356.
   PubMed Web of Science ®Google Scholar
• Schroder NW, Morath S, Alexander C, et al. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem. 2003;278(18):15587–15594.
   PubMed Web of Science ®Google Scholar
• Pilz G, Wipfler P, Otto F, et al. Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study. J Neuroinflammation. 2019;16(1):13.
   PubMedGoogle Scholar
• Ramesh G, Didier PJ, England JD, et al. Inflammation in the pathogenesis of Lyme neuroborreliosis. Am J Pathol. 2015;185(5):1344–1360.
   PubMed Web of Science ®Google Scholar